Thymulin, Research Overview & Evidence

Overview

A zinc-dependent thymic hormone studied for immune regulation and for its effects on inflammatory pain signalling.

Thymulin is classified as a zinc-dependent thymic nonapeptide. Its current development status is: preclinical. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.

The Peptide Institute tracks Thymulin because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.

Independent Testing

Independently tested companies that sell Thymulin

Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.

Companies: 2
Samples: 2
Updated: Aug 11, 2026

1 Verity Research Chemicals Exceptional Institute
Top Rated Thymulin
98.2% average purity across 1 sample
Purity & Testing 98 Transparency 92 Samples 1 90 View company
2 Halcyon Biosciences Excellent
94.6% average purity across 1 sample
Purity & Testing 99 Transparency 90 Samples 1 89 View company

Compare all tested Thymulin companies

Research & Studies

Studies library

A systematic review of Thymulin clinical evidence

Nature Metabolism · Meta-analysis · May 21, 2021

Reports findings relevant to the primary claims made for Thymulin; sample size limits how far the result generalises.
Comparative effects of Thymulin on metabolic endpoints

British Journal of Pharmacology · Preclinical (rodent) · Mar 7, 2021

One of the more methodologically careful entries in the Thymulin literature.
A systematic review of Thymulin clinical evidence

Nature Metabolism · Systematic review · Feb 19, 2014

Adds to the Thymulin evidence base without resolving the central question of human efficacy.